NCT07139860

Brief Summary

The goal of this observational study is to learn about the effectiveness of an artificial intelligence-based early warning system for predicting adverse events in patients with acute myocardial infarction (AMI). The main question it aims to answer is: Does an AI-based early warning system improve the assessment and prediction of adverse events across the full course of AMI care (from prevention to diagnosis, treatment, and rehabilitation)? Participants who are receiving routine medical care for AMI in tertiary hospitals will have their multimodal medical data (clinical records, diagnostic tests, imaging, treatment pathways) collected and analyzed. Data will be integrated using innovative cross-modal representation methods and predictive models. The study will follow patients during their hospital stay and subsequent clinical follow-up to evaluate the feasibility, accuracy, and clinical value of the AI-based early warning system.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,400

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Nov 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Nov 2022Dec 2026

Study Start

First participant enrolled

November 26, 2022

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

August 22, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 24, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

August 24, 2025

Status Verified

August 1, 2025

Enrollment Period

4.1 years

First QC Date

August 22, 2025

Last Update Submit

August 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • MACCE

    Cardiac death All-cause mortality Malignant arrhythmia Non-fatal recurrent myocardial infarction Non-fatal stroke Unplanned repeat revascularization Rehospitalization for heart failure

    1-3 years

Study Arms (2)

BFH

group1

AZH

group2

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1. Retrospective Study Population: Data were obtained from the Cardiovascular Center Database (CBDBank) of Beijing Friendship Hospital. CBDBank is a continuously collected sample dataset of patients with acute coronary syndrome since January 2013. A total of 1,000 patients with acute myocardial infarction admitted to Beijing Friendship Hospital, Capital Medical University, from January 2017 to December 2019 were included in the retrospective cohort. After discharge, all patients received scheduled telephone follow-ups at 1 month, 3 months, 6 months, and annually thereafter, with continuous follow-up for 3 years. 2. Prospective Study Population: A total of 800 patients with acute myocardial infarction admitted to the Cardiovascular Center of Beijing Friendship Hospital from July 2023 to July 2026 will be enrolled in the prospective cohort. Randomization will be performed using random codes, and prognosis prediction will be conducted using either the predictive system or traditional met

You may qualify if:

  • \. Hospitalized patients who meet the diagnostic criteria for acute myocardial infarction. 2. Patients who agree to participate and sign the informed consent form.

You may not qualify if:

  • \. Patients with terminal malignant tumors and an expected survival time of less than 3 months. 2. Patients with complete disability and inability to communicate. 3. Patients unable to comply with follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Friendship Hospital

Beijing, 100050, China

RECRUITING

MeSH Terms

Conditions

ST Elevation Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PHD

Study Record Dates

First Submitted

August 22, 2025

First Posted

August 24, 2025

Study Start

November 26, 2022

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

August 24, 2025

Record last verified: 2025-08

Locations